On October 15, 2025, Davenport & Company LLC disclosed a purchase of 155,551 shares of UnitedHealth Group (UNH) in an SEC Form 13F filing. The transaction was valued at approximately $47.04 million based on the average closing price during Q3 2025.
The purchase increased Davenport’s post‑trade position to 739,525 shares, representing 1.36% of the firm’s $18.76 billion in 13F reportable assets. The stake is the firm’s ninth‑largest position and its ninth‑largest holding overall.
The move follows a significant decline in UnitedHealth’s share price, which fell 40.6% over the prior year. The purchase signals continued institutional confidence in UnitedHealth’s business model despite recent market volatility.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.